Latest News and Press Releases

Encore Creativity for Older Adults receives gift pledge of $1M to expand music programs for those with cognitive change

ALEXANDRIA, VA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA), PA Foundation (PAF), Cleveland Clinic, and Davos Alzheimer’s Collaborative (DAC) today publicly...

ROCHESTER, N.Y., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company, will be reporting novel findings for its lead product, pepinemab, in two...

ROCHESTER, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company, today reports novel findings for its lead product, pepinemab, in a...

Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...

Study shows lifestyle change by pre-dementia and Alzheimer's patients drove better cognitive performance than generally seen in trials of Alzheimer's drugs

ROCHESTER, N.Y., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease...

BOTHELL, Wash., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...

Albuquerque, NM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry, has announced a partnership with leading Alzheimer’s...

The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...